J&J, GSK ready to collaborate on Ebola vaccine work
October 22, 2014 at 06:11 AM EDT
LONDON, Oct 22 (Reuters) - Drugmakers will work together to accelerate development of an Ebola vaccine and Johnson & Johnson and GlaxSmithKline, both of which have experimental vaccine candidates, have already discussed collaboration.